News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
News Conference News ACC 2016 TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral Shelley Wood April 02, 2016
News Conference News ACC 2015 MATRIX Provides Support for Radial Access, Mixed Results for Bivalirudin Todd Neale March 17, 2015
News Conference News ACC 2015 Follow-up TAVR Studies Reassure About Valve Durability, Outcomes Todd Neale March 15, 2015
News Conference News ACC 2014 ZES Plus Tailored Course of Dual Therapy Reduces Adverse Events in Unlikely DES Candidates Yael L. Maxwell March 31, 2014
News Conference News ACC 2012 RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years March 26, 2012
News Conference News ACC 2012 BCIS-1: Long-Term Follow-up Shows Lower Mortality with Elective IABP Therapy Jason Kahn March 25, 2012